{"in_reply_to_user_id": "2836421", "lang": "en", "conversation_id": "1278365284458528772", "attachments": {"media_keys": ["3_1278427679990128646"]}, "entities": {"mentions": [{"start": 0, "end": 6, "username": "MSNBC", "id": "2836421"}, {"start": 7, "end": 22, "username": "VaughnHillyard", "id": "68611923"}], "urls": [{"start": 240, "end": 263, "url": "https://t.co/MhXT1jSYbf", "expanded_url": "http://www.ipharminc.com/press-release/2020/6/17/innovation-pharmaceuticals-brilacidin-inhibits-sars-cov-2-covid-19-by-97-percent-in-a-human-lung-cell-line", "display_url": "ipharminc.com/press-release/\u2026"}, {"start": 264, "end": 287, "url": "https://t.co/onrr6eqLo6", "expanded_url": "https://twitter.com/UltimateDoc2/status/1278427684054470656/photo/1", "display_url": "pic.twitter.com/onrr6eqLo6"}]}, "context_annotations": [{"domain": {"id": "45", "name": "Brand Vertical", "description": "Top level entities that describe a Brands industry"}, "entity": {"id": "781974597310615553", "name": "Entertainment"}}, {"domain": {"id": "46", "name": "Brand Category", "description": "Categories within Brand Verticals that narrow down the scope of Brands"}, "entity": {"id": "781974596157181956", "name": "Online Site"}}, {"domain": {"id": "46", "name": "Brand Category", "description": "Categories within Brand Verticals that narrow down the scope of Brands"}, "entity": {"id": "781974597105094656", "name": "TV/Movies Related"}}, {"domain": {"id": "47", "name": "Brand", "description": "Brands and Companies"}, "entity": {"id": "1137022824931921920", "name": "MSNBC"}}, {"domain": {"id": "123", "name": "Ongoing News Story", "description": "Ongoing News Stories like 'Brexit'"}, "entity": {"id": "1220701888179359745", "name": "COVID-19"}}], "reply_settings": "everyone", "public_metrics": {"retweet_count": 0, "reply_count": 0, "like_count": 0, "quote_count": 0}, "source": "Twitter for iPhone", "id": "1278427684054470656", "referenced_tweets": [{"type": "replied_to", "id": "1278365284458528772"}], "text": "@MSNBC @VaughnHillyard Let\u2019s get Brilacidin into human clinical trials.  It has inhibited COVID-19 by 97% in human lung cells and has already proven safe for human use in other indications. Let\u2019s get it it to the front of the line already.\nhttps://t.co/MhXT1jSYbf https://t.co/onrr6eqLo6", "author_id": "1274908479556370434", "possibly_sensitive": false, "created_at": "2020-07-01T20:38:06.000Z"}